In luminal subtype B, high AGR3 expression was associated with high risk of recurrence and metastasis and poor prognosis in patients with invasive breast carcinoma.13In addition, AGR3 appears to have protumor functions in breast cancer, by regulating the adhesion and migration processes of tumor cells through the activation of Src kinases.22 Here, AGR3 is linked to neoplasm.